Quantcast
Environmental News for a Healthier Planet and Life

More Monsanto Roundup Cancer Trials Expected to Be Postponed

Health + Wellness
More Monsanto Roundup Cancer Trials Expected to Be Postponed
Activists stage a flash protest organized by the international movement Attac at the offices of Bayer in Paris on March 14, 2019. PHILIPPE LOPEZ / AFP via Getty Images

Update, Jan. 8: On Wednesday, St. Louis County Court spokeswoman Christine Bertelson confirmed that one trial set to start Jan. 27 has been officially postponed with no new trial date yet set. That trial was to pit a woman named Sharlean Gordon against Monsanto.

By Carey Gillam

Discussions are underway to postpone one or more highly anticipated Roundup cancer trials set to start in January, including trials scheduled for St. Louis, the former hometown of Roundup herbicide maker Monsanto Co., according to sources close to the litigation.


Court dockets still show trials scheduled for later this month in St. Louis and in California courts, and court officials say they are still planning for the trials to take place on the designated dates. But multiple legal sources said the opposing sides were nearing agreements that would put off the trials by several months, if not longer. Attorneys for Monsanto and for the plaintiffs in the upcoming January trials declined to comment.

The talk of trial delays is not unexpected. Bayer AG, the German company that bought Monsanto in June 2018, successfully negotiated the postponement of several trials that had been set for the fall of 2019 after losing each of the three trials held to date. Each involved plaintiffs who claimed their cancers were caused by exposure to Roundup and other Monsanto glyphosate-based herbicides.

The juries found not just that the company's herbicides can cause cancer, but that Monsanto knew about the risks and hid the information from consumers. Bayer has estimated more than 42,700 people have filed claims in the U.S. against Monsanto, which is now a wholly owned unit of Bayer.

Bayer and a team of plaintiffs' attorneys have been pursuing a potential settlement of the litigation that could amount to well more than $8 billion, the legal sources said.

Bayer has been particularly uneasy about trials scheduled for St. Louis, where former Monsanto CEO Hugh Grant has been subpoenaed to testify and the trial of plaintiff Sharlean Gordon was to be broadcast to the public. In the three previous trials, all held in California, Monsanto executives have given testimony through depositions and have not had to take the stand in front of juries.

"Trial postponements make perfect sense right now," said Susquehanna Financial Group analyst Tom Claps. "I believe that it is in everyone's best interest to stay out of the courtroom at this time, especially when negotiations seem to be progressing in a positive manner."

Amid the maneuvering, more cases continue to stack up. Lawyers for Monsanto were in court Monday in Independence, Missouri to set a schedule and trial date for a newly filed lawsuit brought by a woman suffering from non-Hodgkin lymphoma she claims she developed due to her residential use of Roundup.

Gregory Chernack of the Washington, DC-based Hollingsworth law firm, one of Monsanto's long-serving defense firms, told the judge in Independence that Monsanto wanted the case consolidated with roughly 30 others being overseen by a different judge in Kansas City, Missouri. Attorneys for plaintiff Sheila Carver objected to the suggestion, and asked the judge to go ahead and set a trial date. Jackson County Circuit Court Judge Jennifer Phillips decided to give the parties 30 days to file motions on the matter.

Bayer's annual shareholders' meeting is set for April 28 and analysts said investors would like to see either a settlement of the litigation by that time, or at least meaningful progress in containing the liability. Bayer's stock took a dive, losing billions of dollars in value, after the first jury verdict in August 2018, and share prices remain depressed.

"Bayer's stock has reacted negatively to each of the three trial verdicts. Therefore, Bayer does not want to face more negative trial headlines from losing another trial, especially while it is engaged in good faith settlement discussions," said Claps.

There are multiple factors at play, however, including the uncertainty surrounding the outcome of the appeals that are pending for each of the three trials. If an appellate court were to overturn the jury findings of Monsanto's liability, it would weaken the plaintiffs' bargaining power for a global settlement. Conversely, the company's position would be weakened if the jury verdicts are upheld on appeal. But no decision is expected on the appeals for several more months at least.

In December, the U.S. Department of Justice took the rare step of intervening in the litigation to side with Monsanto and Bayer in the appeal of one of the verdicts.

Reposted with permission from U.S. Right to Know.

Matthew Micah Wright / The Image Bank / Getty Images

By Deborah Moore, Michael Simon and Darryl Knudsen

There's some good news amidst the grim global pandemic: At long last, the world's largest dam removal is finally happening.

Read More Show Less

EcoWatch Daily Newsletter

Scrap metal is loaded into a shredder at a metal recycling facility on July 17, 2008 in Chicago, Illinois. Scott Olson / Getty Images

Hunger strikers in Chicago are fighting the relocation of a metal shredding facility from a white North Side neighborhood to a predominantly Black and Latinx community on the Southeast Side already plagued by numerous polluting industries.

Read More Show Less

Trending

A new UK study links eating meat with increased risks for heart disease, diabetes and more. nata_zhekova / Getty Images

The World Health Organization has determined that red meat probably causes colorectal cancer in humans and that processed meat is carcinogenic to humans. But are there other health risks of meat consumption?

Read More Show Less
A common cuttlefish like this can pass the "marshmallow test." Hans Hillewaert / CC BY-SA 4.0

Cuttlefish, marine invertebrates related to squids and octopuses, can pass the so-called "marshmallow test," an experiment designed to test whether human children have the self-control to wait for a better reward.

Read More Show Less
Yogyakarta Bird Market, Central Java, Indonesia. Jorge Franganillo / CC BY 2.0

By John R. Platt

The straw-headed bulbul doesn't look like much.

It's less than a foot in length, with subdued brown-and-gold plumage, a black beak and beady red eyes. If you saw one sitting on a branch in front of you, you might not give it a second glance.

Read More Show Less